Stroke Remains a Dominant Global Cause of Death and Disability
Stroke held its place as one of the most consequential neurologic conditions in 2021, accounting for 7.3 million deaths and 160.5 million disability-adjusted life-years worldwide. It was the third most common GBD level 3 cause of death and the fourth most common cause of DALYs, a burden large enough to shape health systems far beyond neurology wards. The numbers are not abstract. They reflect emergency transports, intensive care admissions, long inpatient recoveries, chronic disability, caregiver strain, and the long tail of vascular brain injury that follows survivors into outpatient life.
Global case counts were also enormous: 93.8 million prevalent strokes and 11.9 million incident strokes in 2021. Ischemic stroke made up 65.3% of incident events, while intracerebral hemorrhage accounted for 28.8% and subarachnoid hemorrhage for 5.8%. Those proportions matter clinically because each subtype carries a different mix of prevention targets, acute treatment pathways, and long-term impairment. Ischemic events dominate numerically, but hemorrhagic strokes remain a major driver of fatality and severe disability.
Incidence Has Stalled Since 2015 in Several Parts of the World
The clearest warning signal in the analysis is the plateau in stroke incidence reduction after 2015. In some regions, the trend has reversed outright, with increases in stroke incidence, deaths, prevalence, and DALY rates in southeast Asia, east Asia, and Oceania, as well as in countries with lower Socio-demographic Index values and among people younger than 70 years. A disease once expected to decline more steadily with better blood pressure control, smoking reduction, and improved acute care is proving harder to bend downward in multiple settings.
This pattern points to an uneven collision between prevention and exposure. Aging populations explain part of the burden, but they do not account for the full rise in younger adults or in lower-SDI settings. Persistent hypertension, worsening metabolic risk, environmental exposures, and gaps in access to prevention and rehabilitation all likely contribute to the stalled progress. The result is a widening gap between what modern stroke medicine can achieve in theory and what many health systems can deliver consistently in practice.
Blood Pressure and Metabolic Risk Still Drive Most Preventable Harm
The burden attributable to high systolic blood pressure remained central, but several other risks increased more sharply over time. DALYs attributable to high BMI rose by 88.2%, high ambient temperature by 72.4%, high fasting plasma glucose by 32.1%, diet high in sugar-sweetened beverages by 23.4%, low physical activity by 11.3%, lead exposure by 6.5%, and diet low in omega-6 polyunsaturated fatty acids by 5.3%. The rise tied to high systolic blood pressure was smaller than some other risk shifts, yet its absolute importance remains formidable because hypertension drives both ischemic and hemorrhagic stroke across populations.
The biology is straightforward and unforgiving. Elevated arterial pressure injures small vessels, accelerates atherosclerosis, destabilizes plaque, and increases the likelihood of vessel rupture in the brain. High fasting glucose and excess body weight add inflammatory and endothelial stress, while inactivity and poor dietary patterns reinforce insulin resistance, dyslipidemia, and vascular dysfunction. Environmental heat and lead exposure expand the prevention agenda beyond the clinic. Stroke prevention is no longer only a matter of prescribing antihypertensives and antithrombotics; it also requires attention to heat exposure, air quality, diet quality, and metabolic health.
Regional Inequities Are Now Part of the Stroke Story
Across 204 countries and territories, the burden was not evenly distributed. The analysis found clear differences by GBD region, country or territory, and SDI quintile. Those differences are not merely statistical variation. They reflect whether communities can diagnose hypertension early, treat it continuously, manage diabetes and obesity, deliver thrombolysis and thrombectomy when indicated, and provide rehabilitation after the acute phase has passed.
Age-standardised rates are particularly useful here because they separate population growth and aging from changes in underlying risk. Even with that adjustment, the burden has remained high, and in some places has increased. Younger adults in lower-SDI settings are carrying a larger share than expected, raising concern about earlier vascular injury, delayed diagnosis, and lower access to prevention. When stroke shifts earlier in life, the social and economic consequences spread over decades rather than years.
Why the Findings Matter for Prevention, Acute Care, and Rehabilitation
The clinical implications are immediate. Stroke systems must be built for prevention first, because the greatest gains still come from reducing exposure before the first event occurs. Blood pressure control remains the anchor, but the risk profile in this analysis argues for broader and more coordinated action across weight management, glucose control, physical activity, diet, and environmental health. The burden tied to lead exposure and high ambient temperature is especially important for policymakers because these risks sit partly outside traditional neurology and cardiology workflows.
Acute stroke care still matters enormously. Rapid diagnosis, access to reperfusion for eligible ischemic stroke patients, and appropriate management of hemorrhagic stroke can alter survival and disability. Rehabilitation matters just as much, because the DALY count captures the disability that persists after the emergency phase ends. In many countries, the acute event receives more attention than the months and years that follow. The burden data argue for a more continuous model of stroke care that stretches from primary prevention to long-term recovery.
One sentence captures the central message. Stroke is still rising where prevention and access are weakest.
A Global Call for Surveillance and Resource Allocation
The estimate set spans 1990 through 2021 and used standard GBD methods across 500 draws to generate uncertainty intervals for each estimate. Its reach across countries, regions, and SDI quintiles gives it unusual policy value. Health ministries can use these numbers to prioritize blood pressure programs, metabolic screening, smoking control, food policy, and rehabilitation capacity. Clinicians can use them to frame stroke as a multisectoral disease shaped by vascular biology, environmental exposure, and health-system access.
The remaining challenge is operational, not conceptual. Many of the risks identified here are modifiable, yet the burden continues to rise because prevention is uneven, treatment is delayed, and rehabilitation is incomplete. The data make one point hard to ignore: stroke control will require sustained investment in surveillance, primary prevention, emergency systems, and post-stroke care across settings with very different resources and risk profiles.